You are here

Disease Prevention

FDA authorizes Covid-19 vaccines for younger children

...

Moderna's vaccine is now authorized for use in children 6 months through 17 years and Pfizer/BioNTech's for children 6 months through 4 years. About 17 million kids under the age of 5 are now are eligible for Covid-19 vaccines...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Paxlovid Misses in Standard-Risk COVID-19

Updated findings from a nirmatrelvir/ritonavir (Paxlovid) trial in standard-risk COVID-19 suggest the antiviral's benefits are less clear for those not at high risk of severe outcomes.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Disease Prevention
howdy folks
Page loaded in 0.770 seconds.